Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Change in Inventory (2022 - 2024)

Tvardi Therapeutics' Change in Inventory history spans 3 years, with the latest figure at $729000.0 for Q4 2024.

  • On a quarterly basis, Change in Inventory rose 263.82% to $729000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $1.0 million, a 137.9% increase, with the full-year FY2024 number at $1.0 million, up 137.9% from a year prior.
  • Change in Inventory hit $729000.0 in Q4 2024 for Tvardi Therapeutics, up from $1000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for TVRD hit a ceiling of $1.6 million in Q2 2022 and a floor of -$1.6 million in Q3 2022.
  • Historically, Change in Inventory has averaged $106583.3 across 3 years, with a median of -$39500.0 in 2024.
  • Biggest five-year swings in Change in Inventory: tumbled 181.2% in 2023 and later soared 512.63% in 2024.
  • Tracing TVRD's Change in Inventory over 3 years: stood at $548000.0 in 2022, then tumbled by 181.2% to -$445000.0 in 2023, then surged by 263.82% to $729000.0 in 2024.
  • Business Quant data shows Change in Inventory for TVRD at $729000.0 in Q4 2024, $1000.0 in Q3 2024, and $392000.0 in Q2 2024.